- Home
- TLSI vs INVZ Comparison
TLSI vs INVZ Comparison
Compare TLSI & INVZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- INVZ
- Stock Information
- Founded
- TLSI 2010
- INVZ 2016
- Country
- TLSI United States
- INVZ Israel
- Employees
- TLSI N/A
- INVZ N/A
- Industry
- TLSI Medical Specialities
- INVZ Auto Parts:O.E.M.
- Sector
- TLSI Health Care
- INVZ Consumer Discretionary
- Exchange
- TLSI Nasdaq
- INVZ Nasdaq
- Market Cap
- TLSI 204.0M
- INVZ 186.3M
- IPO Year
- TLSI N/A
- INVZ N/A
- Fundamental
- Price
- TLSI $5.54
- INVZ $1.36
- Analyst Decision
- TLSI Strong Buy
- INVZ Strong Buy
- Analyst Count
- TLSI 5
- INVZ 5
- Target Price
- TLSI $10.90
- INVZ $3.38
- AVG Volume (30 Days)
- TLSI 39.7K
- INVZ 6.7M
- Earning Date
- TLSI 08-13-2025
- INVZ 08-06-2025
- Dividend Yield
- TLSI N/A
- INVZ N/A
- EPS Growth
- TLSI N/A
- INVZ N/A
- EPS
- TLSI N/A
- INVZ N/A
- Revenue
- TLSI $32,141,000.00
- INVZ $34,601,000.00
- Revenue This Year
- TLSI $55.52
- INVZ $137.25
- Revenue Next Year
- TLSI $54.76
- INVZ $128.53
- P/E Ratio
- TLSI N/A
- INVZ N/A
- Revenue Growth
- TLSI 46.20
- INVZ 28.52
- 52 Week Low
- TLSI $3.50
- INVZ $0.45
- 52 Week High
- TLSI $6.08
- INVZ $3.14
- Technical
- Relative Strength Index (RSI)
- TLSI 53.07
- INVZ 82.66
- Support Level
- TLSI $5.18
- INVZ $0.90
- Resistance Level
- TLSI $5.54
- INVZ $1.02
- Average True Range (ATR)
- TLSI 0.32
- INVZ 0.10
- MACD
- TLSI 0.01
- INVZ 0.05
- Stochastic Oscillator
- TLSI 82.81
- INVZ 93.43
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About INVZ Innoviz Technologies Ltd. Ordinary shares
Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.